Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
When growing up, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of drugs change, which may alter the effect of drugs. To ensure optimal drug efficacy and safety in paediatric care, PK and PD relationships of drugs need to be explored in children. This article presents an outline on perfo...
Gespeichert in:
Veröffentlicht in: | Archives of disease in childhood 2014-03, Vol.99 (3), p.267-272 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 272 |
---|---|
container_issue | 3 |
container_start_page | 267 |
container_title | Archives of disease in childhood |
container_volume | 99 |
creator | Admiraal, Rick van Kesteren, Charlotte Boelens, Jaap Jan Bredius, Robbert G M Tibboel, Dick Knibbe, Catherijne A J |
description | When growing up, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of drugs change, which may alter the effect of drugs. To ensure optimal drug efficacy and safety in paediatric care, PK and PD relationships of drugs need to be explored in children. This article presents an outline on performing a population PK/PD study and translating these results into rational dosing regimens, with the development and prospective evaluation of PK/PD derived evidence-based dosing regimen being discussed. Examples on amikacin, morphine and busulfan are provided, showing how PK(/PD) modelling not only led to optimization and individualization in paediatric clinical care for the specific drugs but also to insight in maturation of organ systems involved. It is shown that the latter results can subsequently be used as a basis for dosing of other drugs eliminated through the same pathway. Ultimately, these efforts should lead to predictable drug efficacy and safety across all age groups. |
doi_str_mv | 10.1136/archdischild-2013-303721 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1499155579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A370687692</galeid><sourcerecordid>A370687692</sourcerecordid><originalsourceid>FETCH-LOGICAL-b455t-7fc1765aff8f898718171eca9e3bb6d6beb5b7c341256306b31993e5367e9dbe3</originalsourceid><addsrcrecordid>eNqNkU2LFDEQhoMo7rj6FyQggpfWpNOdj-My-AULe1nPIR_VMxm7kzHpdt1_b8YeV_HkKVR4quqhXoQwJW8pZfydyW7vQ3H7MPqmJZQ1jDDR0kdoQzsu61fXPUYbQghrlJTyAj0r5UAIbaVkT9FF27GeSyI26O423ZnsC4bvwUN00FhTwGOfSog7nGEXJogFh4h_bcsQcYp43gOuYCg4DfiYjsto5lD_j3uTJ-PS1xBhDu6h9vfRTLWekodxrJOfoyeDGQu8OL-X6MuH97fbT831zcfP26vrxnZ9PzdicFTw3gyDHKSSgkoqKDijgFnLPbdgeysc62jbc0a4ZVQpBj3jApS3wC7Rm3XuMadvC5RZT_Vu1cFESEvRtFOK9n0vVEVf_YMe0pJjtdNU1sNJRsiJalZqZ0bQIboUZ_gxuzSOsANd5bc3-ooJwqXgqq28XHmXUykZBn3MYTL5XlOiT2Hqv8PUpzD1GmZtfXkWWuwE_qHxd3oVeH0GTHFmHLKJLpQ_XLVmip6c2crZ6fD_638Cu7W8-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1828883009</pqid></control><display><type>article</type><title>Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><creator>Admiraal, Rick ; van Kesteren, Charlotte ; Boelens, Jaap Jan ; Bredius, Robbert G M ; Tibboel, Dick ; Knibbe, Catherijne A J</creator><creatorcontrib>Admiraal, Rick ; van Kesteren, Charlotte ; Boelens, Jaap Jan ; Bredius, Robbert G M ; Tibboel, Dick ; Knibbe, Catherijne A J</creatorcontrib><description>When growing up, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of drugs change, which may alter the effect of drugs. To ensure optimal drug efficacy and safety in paediatric care, PK and PD relationships of drugs need to be explored in children. This article presents an outline on performing a population PK/PD study and translating these results into rational dosing regimens, with the development and prospective evaluation of PK/PD derived evidence-based dosing regimen being discussed. Examples on amikacin, morphine and busulfan are provided, showing how PK(/PD) modelling not only led to optimization and individualization in paediatric clinical care for the specific drugs but also to insight in maturation of organ systems involved. It is shown that the latter results can subsequently be used as a basis for dosing of other drugs eliminated through the same pathway. Ultimately, these efforts should lead to predictable drug efficacy and safety across all age groups.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2013-303721</identifier><identifier>PMID: 24356807</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group</publisher><subject>Alkylating Agents - administration & dosage ; Alkylating Agents - pharmacokinetics ; Amikacin - administration & dosage ; Amikacin - pharmacokinetics ; Analgesics, Opioid - administration & dosage ; Analgesics, Opioid - pharmacokinetics ; Anti-Bacterial Agents - pharmacokinetics ; Biological and medical sciences ; Body Composition ; Body Weight ; Busulfan - administration & dosage ; Busulfan - pharmacokinetics ; Child ; Company business management ; Dose-Response Relationship, Drug ; Evidence ; Evidence-Based Medicine ; General aspects ; Health aspects ; Humans ; Infant health services ; Management ; Medical sciences ; Miscellaneous ; Models, Biological ; Morphine - administration & dosage ; Morphine - pharmacokinetics ; Narcotics ; Neonates ; Patients ; Pediatrics ; Pharmacokinetics ; Pharmacology ; Prevention and actions ; Profiles ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Sampling ; Statistical Analysis</subject><ispartof>Archives of disease in childhood, 2014-03, Vol.99 (3), p.267-272</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>2015 INIST-CNRS</rights><rights>Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b455t-7fc1765aff8f898718171eca9e3bb6d6beb5b7c341256306b31993e5367e9dbe3</citedby><cites>FETCH-LOGICAL-b455t-7fc1765aff8f898718171eca9e3bb6d6beb5b7c341256306b31993e5367e9dbe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://adc.bmj.com/content/99/3/267.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://adc.bmj.com/content/99/3/267.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,313,314,776,780,788,3183,23550,27899,27901,27902,77343,77374</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28283919$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24356807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Admiraal, Rick</creatorcontrib><creatorcontrib>van Kesteren, Charlotte</creatorcontrib><creatorcontrib>Boelens, Jaap Jan</creatorcontrib><creatorcontrib>Bredius, Robbert G M</creatorcontrib><creatorcontrib>Tibboel, Dick</creatorcontrib><creatorcontrib>Knibbe, Catherijne A J</creatorcontrib><title>Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>When growing up, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of drugs change, which may alter the effect of drugs. To ensure optimal drug efficacy and safety in paediatric care, PK and PD relationships of drugs need to be explored in children. This article presents an outline on performing a population PK/PD study and translating these results into rational dosing regimens, with the development and prospective evaluation of PK/PD derived evidence-based dosing regimen being discussed. Examples on amikacin, morphine and busulfan are provided, showing how PK(/PD) modelling not only led to optimization and individualization in paediatric clinical care for the specific drugs but also to insight in maturation of organ systems involved. It is shown that the latter results can subsequently be used as a basis for dosing of other drugs eliminated through the same pathway. Ultimately, these efforts should lead to predictable drug efficacy and safety across all age groups.</description><subject>Alkylating Agents - administration & dosage</subject><subject>Alkylating Agents - pharmacokinetics</subject><subject>Amikacin - administration & dosage</subject><subject>Amikacin - pharmacokinetics</subject><subject>Analgesics, Opioid - administration & dosage</subject><subject>Analgesics, Opioid - pharmacokinetics</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Body Composition</subject><subject>Body Weight</subject><subject>Busulfan - administration & dosage</subject><subject>Busulfan - pharmacokinetics</subject><subject>Child</subject><subject>Company business management</subject><subject>Dose-Response Relationship, Drug</subject><subject>Evidence</subject><subject>Evidence-Based Medicine</subject><subject>General aspects</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Infant health services</subject><subject>Management</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Models, Biological</subject><subject>Morphine - administration & dosage</subject><subject>Morphine - pharmacokinetics</subject><subject>Narcotics</subject><subject>Neonates</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Pharmacokinetics</subject><subject>Pharmacology</subject><subject>Prevention and actions</subject><subject>Profiles</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Sampling</subject><subject>Statistical Analysis</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkU2LFDEQhoMo7rj6FyQggpfWpNOdj-My-AULe1nPIR_VMxm7kzHpdt1_b8YeV_HkKVR4quqhXoQwJW8pZfydyW7vQ3H7MPqmJZQ1jDDR0kdoQzsu61fXPUYbQghrlJTyAj0r5UAIbaVkT9FF27GeSyI26O423ZnsC4bvwUN00FhTwGOfSog7nGEXJogFh4h_bcsQcYp43gOuYCg4DfiYjsto5lD_j3uTJ-PS1xBhDu6h9vfRTLWekodxrJOfoyeDGQu8OL-X6MuH97fbT831zcfP26vrxnZ9PzdicFTw3gyDHKSSgkoqKDijgFnLPbdgeysc62jbc0a4ZVQpBj3jApS3wC7Rm3XuMadvC5RZT_Vu1cFESEvRtFOK9n0vVEVf_YMe0pJjtdNU1sNJRsiJalZqZ0bQIboUZ_gxuzSOsANd5bc3-ooJwqXgqq28XHmXUykZBn3MYTL5XlOiT2Hqv8PUpzD1GmZtfXkWWuwE_qHxd3oVeH0GTHFmHLKJLpQ_XLVmip6c2crZ6fD_638Cu7W8-Q</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Admiraal, Rick</creator><creator>van Kesteren, Charlotte</creator><creator>Boelens, Jaap Jan</creator><creator>Bredius, Robbert G M</creator><creator>Tibboel, Dick</creator><creator>Knibbe, Catherijne A J</creator><general>BMJ Publishing Group</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20140301</creationdate><title>Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling</title><author>Admiraal, Rick ; van Kesteren, Charlotte ; Boelens, Jaap Jan ; Bredius, Robbert G M ; Tibboel, Dick ; Knibbe, Catherijne A J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b455t-7fc1765aff8f898718171eca9e3bb6d6beb5b7c341256306b31993e5367e9dbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Alkylating Agents - administration & dosage</topic><topic>Alkylating Agents - pharmacokinetics</topic><topic>Amikacin - administration & dosage</topic><topic>Amikacin - pharmacokinetics</topic><topic>Analgesics, Opioid - administration & dosage</topic><topic>Analgesics, Opioid - pharmacokinetics</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Body Composition</topic><topic>Body Weight</topic><topic>Busulfan - administration & dosage</topic><topic>Busulfan - pharmacokinetics</topic><topic>Child</topic><topic>Company business management</topic><topic>Dose-Response Relationship, Drug</topic><topic>Evidence</topic><topic>Evidence-Based Medicine</topic><topic>General aspects</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Infant health services</topic><topic>Management</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Models, Biological</topic><topic>Morphine - administration & dosage</topic><topic>Morphine - pharmacokinetics</topic><topic>Narcotics</topic><topic>Neonates</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Pharmacokinetics</topic><topic>Pharmacology</topic><topic>Prevention and actions</topic><topic>Profiles</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Sampling</topic><topic>Statistical Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Admiraal, Rick</creatorcontrib><creatorcontrib>van Kesteren, Charlotte</creatorcontrib><creatorcontrib>Boelens, Jaap Jan</creatorcontrib><creatorcontrib>Bredius, Robbert G M</creatorcontrib><creatorcontrib>Tibboel, Dick</creatorcontrib><creatorcontrib>Knibbe, Catherijne A J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Admiraal, Rick</au><au>van Kesteren, Charlotte</au><au>Boelens, Jaap Jan</au><au>Bredius, Robbert G M</au><au>Tibboel, Dick</au><au>Knibbe, Catherijne A J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>99</volume><issue>3</issue><spage>267</spage><epage>272</epage><pages>267-272</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><abstract>When growing up, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of drugs change, which may alter the effect of drugs. To ensure optimal drug efficacy and safety in paediatric care, PK and PD relationships of drugs need to be explored in children. This article presents an outline on performing a population PK/PD study and translating these results into rational dosing regimens, with the development and prospective evaluation of PK/PD derived evidence-based dosing regimen being discussed. Examples on amikacin, morphine and busulfan are provided, showing how PK(/PD) modelling not only led to optimization and individualization in paediatric clinical care for the specific drugs but also to insight in maturation of organ systems involved. It is shown that the latter results can subsequently be used as a basis for dosing of other drugs eliminated through the same pathway. Ultimately, these efforts should lead to predictable drug efficacy and safety across all age groups.</abstract><cop>London</cop><pub>BMJ Publishing Group</pub><pmid>24356807</pmid><doi>10.1136/archdischild-2013-303721</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-9888 |
ispartof | Archives of disease in childhood, 2014-03, Vol.99 (3), p.267-272 |
issn | 0003-9888 1468-2044 |
language | eng |
recordid | cdi_proquest_miscellaneous_1499155579 |
source | MEDLINE; BMJ Journals - NESLi2 |
subjects | Alkylating Agents - administration & dosage Alkylating Agents - pharmacokinetics Amikacin - administration & dosage Amikacin - pharmacokinetics Analgesics, Opioid - administration & dosage Analgesics, Opioid - pharmacokinetics Anti-Bacterial Agents - pharmacokinetics Biological and medical sciences Body Composition Body Weight Busulfan - administration & dosage Busulfan - pharmacokinetics Child Company business management Dose-Response Relationship, Drug Evidence Evidence-Based Medicine General aspects Health aspects Humans Infant health services Management Medical sciences Miscellaneous Models, Biological Morphine - administration & dosage Morphine - pharmacokinetics Narcotics Neonates Patients Pediatrics Pharmacokinetics Pharmacology Prevention and actions Profiles Public health. Hygiene Public health. Hygiene-occupational medicine Sampling Statistical Analysis |
title | Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A03%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Towards%20evidence-based%20dosing%20regimens%20in%20children%20on%20the%20basis%20of%20population%20pharmacokinetic%20pharmacodynamic%20modelling&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Admiraal,%20Rick&rft.date=2014-03-01&rft.volume=99&rft.issue=3&rft.spage=267&rft.epage=272&rft.pages=267-272&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/archdischild-2013-303721&rft_dat=%3Cgale_proqu%3EA370687692%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1828883009&rft_id=info:pmid/24356807&rft_galeid=A370687692&rfr_iscdi=true |